2C-P
| Clinical data | |
|---|---|
| Other names | 2C-Pr; 4-Propyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-propylphenethylamine; 2C-DOPR; 2C-DOPr; Selene |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 1–2 hours Peak: 3 hours |
| Duration of action | 10–16 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H21NO2 |
| Molar mass | 223.316 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 207 to 209 °C (405 to 408 °F) (hydrochloride) |
| Solubility in water | 7–9 mg/mL (20 °C) mg/mL (20 °C) |
| |
| |
| (verify) | |
2C-P, also known as 4-propyl-2,5-dimethoxyphenethylamine or as Selene, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally and is among the most potent and long-lasting of the 2C psychedelics.
2C-P was first described in the literature by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.